uMRD-negative status linked to recurrence-free outcomes with nadofaragene firadenovec in NMIBC
Jason Scovell
Advertisement
Articles by Jason Scovell
Surgery after neoadjuvant immune checkpoint inhibitor therapy for renal cell carcinoma is safe even in challenging surgical cases, according to Jason Scovell, MD.
Advertisement
Latest Updated Articles
Nadofaragene Firadenovec Results in uMRD-Negative Status in NMBICJanuary 28th 2024
Advertisement
Advertisement
Trending on CancerNetwork
1
Enolen Displays 84% Reduction in Tumor Volume of Localized Prostate Cancer
2
FDA Receives NDA Resubmission for 18F-FET PET Imaging Agent in Recurrent Glioma
3
Insights Across Hematologic Oncology at Columbia University
4
Supervised Keto Diet/Triplet Chemo Improves Survival in Pancreatic Cancer
5